top of page
disruptive, patented tech platform
redbiotec provides a disruptive, patented technology platform to develop and produce innovative therapies and biomanufacturing solutions based on protein complexes and engineered microorganisms. founded in 2006 as a spin-off of eth zürich, the company has since won several awards, including the renowned w.a. de vigier award.
rac I
biotech
2009
2006
fund
sector
invested in
founded
bottom of page